Sign Up Today and Learn More About LatchBio Stock
Invest in or calculate the value of your shares in LatchBio or other pre-IPO companies through EquityZen's platform.
LatchBio Stock (LABI)
LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.
About LatchBio Stock
Founded
2021
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
LatchBio Press Mentions
Stay in the know about the latest news on LatchBio
LatchBio Releases a 25 Million Cell Human Spatial Transcriptomics Atlas and Agentic Spatial Curation Tools
businesswire • Sep 05, 2025
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
biospace • Jun 27, 2025
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentic AI Framework for Molecular Data Curation
businesswire • Jun 27, 2025
New Products Posted to GenomeWeb: Miraomics, Pythia Biosciences, LatchBio, Devyser, Zeptometrix
genomeweb • Jun 27, 2025
Mendaera Raises $24M in Series A Funding
finsmes • Dec 24, 2023
LatchBio Management
Leadership team at LatchBio
Co-Founder and CEO
Alfredo Andere
Co-founder and CTO
Kenny Workman
Join now and verify your accreditation status to gain access to:
- LatchBio Current Valuation
- LatchBio Stock Price
- LatchBio Management
- Available deals in LatchBio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- LatchBio Cap Table and Funding History by Share Class and Liquidity Preferences
- LatchBio Revenue and Financials
- LatchBio Highlights
- LatchBio Business Model
- LatchBio Risk Factors
- LatchBio Research Report from SACRA Research
Trading LatchBio Stock
How to invest in LatchBio stock?
Accredited investors can buy pre-IPO stock in companies like LatchBio through EquityZen funds. These investments are made available by existing LatchBio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell LatchBio stock?
Shareholders can sell their LatchBio stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
